Reuters reported the approval as Novo shares sit down 13% this year. STEP Young data in kids aged 6 to 11 is due at ObesityWeek in November.
Recap by typeshit. Full story at ad-hoc-news.de.
The 52-year-old actor points to his early 4am workouts and discipline instead of weight loss shots. A celebrity opinion, not new data.
Metz says the drug improved her mobility enough to handle eight Broadway shows a week in "& Juliet". Her account, not a clinical claim.
A general piece on how GLP-1 drugs like Ozempic and Wegovy reshaped weight management in the US. Light on new details.
The broker says Laurus beat 2QFY27 estimates on EBITDA and profit, with its CDMO pipeline and peptide work driving the higher forecasts.
An official Gov.il notice flags illegal peptides marketed for weight loss and muscle building as a possible health risk. Details are on the government page.
16:32
Dr. Kevin Joseph, DO, who treats liver disease daily, shares his views on peptides. The claims are his own, not established treatment guidance.
Loading…